Changes in Hong Kong stocks | Jinhai Medical Technology (02225) rose nearly 8% in early trading, Hong Kong Stock Connect's shareholding ratio rose rapidly, and the revenue structure in the first half of the year was significantly optimized

The Zhitong Finance App learned that Jinhai Medical Technology (02225) rose nearly 8% in early trading. As of press release, it rose 5.00% to HK$5.98, with a turnover of HK$15.3049 million.

According to the news, on September 7, Jinhai Medical Technology was officially added to the Hong Kong Stock Connect list. This inclusion will help broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share transactions. According to the data, Beishui Capital has continued to increase its holdings in Jinhai Medical Technology recently. Hong Kong Stock Connect's shareholding ratio rapidly increased from 0.3% on September 10 to 0.7% on September 18

It is worth noting that in the first half of the year, Jinhai Medical Technology's revenue structure was significantly optimized. Revenue related to minimally invasive surgery solutions and medical products was SGD 25.43 million, a sharp increase of 301.5% over the previous year, accounting for 74.73% of total revenue, all from the Chinese market. The financial report also shows that the company calculated Chinese corporate income tax for the first time in the first half of the year, which means that Jinhai's Chinese medical business has already crossed the break-even line in terms of operation.